Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberWO2016071426 A1
Publication typeApplication
Application numberPCT/EP2015/075765
Publication date12 May 2016
Filing date5 Nov 2015
Priority date7 Nov 2014
Also published asCA2966796A1, CN107074776A, EP3018131A1, EP3215507A1
Publication numberPCT/2015/75765, PCT/EP/15/075765, PCT/EP/15/75765, PCT/EP/2015/075765, PCT/EP/2015/75765, PCT/EP15/075765, PCT/EP15/75765, PCT/EP15075765, PCT/EP1575765, PCT/EP2015/075765, PCT/EP2015/75765, PCT/EP2015075765, PCT/EP201575765, WO 2016/071426 A1, WO 2016071426 A1, WO 2016071426A1, WO-A1-2016071426, WO2016/071426A1, WO2016071426 A1, WO2016071426A1
InventorsJan-Georg Peters, Jürgen STIEHL, Kai Lovis
ApplicantBayer Pharma Aktiengesellschaft
Export CitationBiBTeX, EndNote, RefMan
External Links: Patentscope, Espacenet
Synthesis of copanlisib and its dihydrochloride salt
WO 2016071426 A1
Description  available in English
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
WO2008070150A1 *5 Dec 200712 Jun 2008Bayer Schering Pharma AktiengesellschaftSubstituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Non-Patent Citations
1 *FUJIOKA ET AL: "One-pot synthesis of imidazolines from aldehydes: detailed study about solvents and substrates", TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 63, no. 3, 13 December 2006 (2006-12-13), pages 638 - 643, XP005802290, ISSN: 0040-4020, DOI: 10.1016/J.TET.2006.11.007
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
WO2017049983A1 *1 Jul 201630 Mar 2017苏州立新制药有限公司库潘尼西的制备方法
International ClassificationC07D233/24, C07D295/088, C07D487/04
Cooperative ClassificationC07D487/04, C07D233/24, C07D295/088
Legal Events
22 Jun 2016121Ep: the epo has been informed by wipo that ep was designated in this application
Ref document number: 15790141
Country of ref document: EP
Kind code of ref document: A1
10 Apr 2017REEP
Ref document number: 2015790141
Country of ref document: EP
28 Apr 2017ENPEntry into the national phase in:
Ref document number: 20177011704
Country of ref document: KR
Kind code of ref document: A
1 May 2017ENPEntry into the national phase in:
Ref document number: 2017523873
Country of ref document: JP
Kind code of ref document: A
4 May 2017ENPEntry into the national phase in:
Ref document number: 2966796
Country of ref document: CA
8 May 2017NENPNon-entry into the national phase in:
Ref country code: DE
11 May 2017ENPEntry into the national phase in:
Ref document number: 2015341779
Country of ref document: AU
Date of ref document: 20151105
Kind code of ref document: A
30 May 2017REGReference to national code
Ref country code: BR
Ref legal event code: B01A
Ref document number: 112017009471
Country of ref document: BR